Match!

Angiotensin II Induces Interleukin-1β–Mediated Islet Inflammation and β-Cell Dysfunction Independently of Vasoconstrictive Effects

Published on Apr 1, 2015in Diabetes7.199
· DOI :10.2337/db14-1282
Nadine S. Sauter14
Estimated H-index: 14
(University of Basel),
Constanze Thienel5
Estimated H-index: 5
(University of Basel)
+ 10 AuthorsMarc Y. Donath60
Estimated H-index: 60
(University of Basel)
Abstract
Pathological activation of the renin-angiotensin system (RAS) is associated with the metabolic syndrome, and the new onset of type 2 diabetes can be delayed by RAS inhibition. In animal models of type 2 diabetes, inhibition of the RAS improves insulin secretion. However, the direct effects of angiotensin II on islet function and underlying mechanisms independent of changes in blood pressure remain unclear. Here we show that exposure of human and mouse islets to angiotensin II induces interleukin (IL)-1–dependent expression of IL-6 and MCP-1, enhances β-cell apoptosis, and impairs mitochondrial function and insulin secretion. In vivo, mice fed a high-fat diet and treated with angiotensin II and the vasodilator hydralazine to prevent hypertension showed defective glucose-stimulated insulin secretion and deteriorated glucose tolerance. Application of an anti–IL-1β antibody reduced the deleterious effects of angiotensin II on islet inflammation, restored insulin secretion, and improved glycemia. We conclude that angiotensin II leads to islet dysfunction via induction of inflammation and independent of vasoconstriction. Our findings reveal a novel role for the RAS and an additional rationale for the treatment of type 2 diabetic patients with an IL-1β antagonist.
  • References (53)
  • Citations (26)
📖 Papers frequently viewed together
20077.20Diabetes
14 Authors (Jan A. Ehses, ..., Marc Y. Donath)
451 Citations
870 Citations
1,255 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References53
Newest
#1Johannes HensenH-Index: 3
#2Campbell P. Howard (Novartis)H-Index: 5
Last. Tom Thuren (Novartis)H-Index: 13
view all 4 authors...
Abstract Aims/hypothesis This study was conducted to determine the optimal monthly subcutaneous dose of canakinumab (a human monoclonal anti-human IL-1β antibody) needed to improve glucose control in metformin-treated patients with type 2 diabetes mellitus (T2DM). Methods This was a parallel-group, randomized, double-blind, multicentre, placebo-controlled study designed to assess the effect on HbA 1c and the safety/tolerability of four monthly doses of canakinumab (5, 15, 50, or 150mg) as an add...
60 CitationsSource
#1Zhen ZhangH-Index: 1
#2Chunyan LiuH-Index: 1
Last. Jianchun WangH-Index: 74
view all 11 authors...
Recent evidence supported the presence of a local renin-angiotensin system (RAS) in the pancreas, which is implicated in many physiological and pathophysiological processes. We utilized small interfering RNA (siRNA) to investigate the effects of angiotensin II type 1 receptor (AT1R) knockdown on glucose-stimulated insulin secretion (GSIS) in isolated islets of db/db mice and to explore the potential mechanisms involved. We found that Ad-siAT1R treatment resulted in a significant decrease both in...
11 CitationsSource
#1Joanne Sloan-Lancaster (Eli Lilly and Company)H-Index: 3
#2Eyas Abu-Raddad (Eli Lilly and Company)H-Index: 3
Last. William H. Landschulz (Eli Lilly and Company)H-Index: 16
view all 8 authors...
OBJECTIVE Inflammation is associated with pancreatic β-cell apoptosis and reduced insulin sensitivity. Literature suggests that interleukin (IL)-1β may contribute to the pathogenesis of type 2 diabetes mellitus (T2DM). This study aimed to determine the efficacy, safety, and tolerability of LY2189102, a neutralizing IL-1β antibody, in T2DM patients. RESEARCH DESIGN AND METHODS Phase II, randomized, double-blind, parallel, placebo-controlled study of subcutaneous LY2189102 (0.6, 18, and 180 mg) ad...
110 CitationsSource
#1Li Yuan (TJMC: Tongji Medical College)H-Index: 1
#2Xin Li (WHU: Wuhan University)H-Index: 2
Last. Suo-suo Cheng (TJMC: Tongji Medical College)H-Index: 1
view all 5 authors...
The renin–angiotensin system (RAS) has an important role in the endocrine pancreas. Multiple researches have shown that even in the insulin resistance phase, there are many abnormalities in islets morphology and function. This study aimed at investigating the effects of RAS blockade on the islets function in rats with long-term high-fat diet and its mechanisms. Wistar rats with 16-week high-fat diet were randomly divided into perindopril intervention group (FP, n = 15) and telmisartan interventi...
19 CitationsSource
#1Eliete Dalla Corte Frantz (UERJ: Rio de Janeiro State University)H-Index: 7
#2Camila Crespo-Mascarenhas (UERJ: Rio de Janeiro State University)H-Index: 1
Last. Mandarim de Lacerda (UERJ: Rio de Janeiro State University)H-Index: 33
view all 5 authors...
Background The associations between obesity, hypertension and diabetes are well established, and the renin-angiotensin system (RAS) may provide a link among them. The effect of RAS inhibition on type 2 diabetes is still unclear; however, RAS seems to play an important role in the regulation of the pancreas and glucose intolerance of mice fed high-fat (HF) diet.
42 CitationsSource
#1Aila Rissanen (UH: University of Helsinki)H-Index: 70
#2C. P. Howard (Novartis)H-Index: 2
Last. Robert LipetzH-Index: 1
view all 53 authors...
Aims: Evaluate anti-interleukin-1β (IL-1β) antibody, canakinumab, in patients with type 2 diabetes and impaired glucose tolerance (IGT) in whom hyperglycaemia may trigger IL-1β-associated inflammation leading to suppressed insulin secretion and β-cell dysfunction. Methods: This 4-week, parallel-group study randomized 190 patients with type 2 diabetes 2:1, canakinumab versus placebo, into the following treatment arms: metformin monotherapy, metformin+ sulfonylurea, metformin + sulfonylurea + thia...
86 CitationsSource
Last. Marc Y. DonathH-Index: 60
view all 10 authors...
OBJECTIVE: Metabolic activation of the innate immune system governed by interleukin (IL)-1beta contributes to beta-cell failure in type 2 diabetes. Gevokizumab is a novel, human-engineered monoclonal anti-IL-1beta antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: In a placebo-controlled, dose-escalation study, a total of 98 patients were randomly assigned to placebo (17 subjects) or gevokizumab (81 subjects) at...
171 CitationsSource
#1Banumathi K. ColeH-Index: 12
#2Susanna R. KellerH-Index: 42
Last. Craig S. NunemakerH-Index: 28
view all 6 authors...
Obesity, hypertension, cardiovascular disease, and inflammation are closely associated with the rising incidence of diabetes mellitus. One pharmacological target that may have significant potential to lower the risk of obesity-related diseases is the angiotensin type 1 receptor (AT1R). We examined the hypothesis that the AT1R blocker valsartan reduces the metabolic consequences and inflammatory effects of a high-fat (Western) diet in mice. C57BL/6J mice were treated by oral gavage with 10 mg/kg ...
74 CitationsSource
#1L. Yuan (TJMC: Tongji Medical College)H-Index: 2
#2X. Li (WHU: Wuhan University)H-Index: 1
Last. C. J. Qi (TJMC: Tongji Medical College)H-Index: 1
view all 4 authors...
Aims: To investigate the effects of renin-angiotensin system (RAS) blockade on islet structure and function in diabetic rats, and its mechanisms. Methods: Diabetic rat models were created by high-fat high-caloric laboratory chow plus small dose (30 mg/kg) streptozotocin ip injection. After 8-week intervention with perindopril (AE, no.=10) or valsartan (AR, no.=10), all the animals’ islet function was evaluated by iv glucose tolerance test. Pancreases were stained by immunohistochemistry techniqu...
29 CitationsSource
#1CamozziH-Index: 1
#2F VesciniH-Index: 1
Last. L. MoroH-Index: 1
view all 4 authors...
Bone matrix is composed mainly of inorganic materials, while the bone organic compartment is a minor and complex structural entity, surrounding and supporting cells. Three major classes of biomolecules are involved in this organic part: structural proteins, specialized proteins, and proteoglycans. This review will briefly summarize our knowledge about the role and regulation of these specific bone components.
8 Citations
Cited By26
Newest
#1Marianne Böni-Schnetzler (University Hospital of Basel)H-Index: 2
#2Daniel T. Meier (University Hospital of Basel)H-Index: 1
Metabolic diseases including type 2 diabetes are associated with meta-inflammation. β-Cell failure is a major component of the pathogenesis of type 2 diabetes. It is now well established that increased numbers of innate immune cells, cytokines, and chemokines have detrimental effects on islets in these chronic conditions. Recently, evidence emerged which points to initially adaptive and restorative functions of inflammatory factors and immune cells in metabolism. In the following review, we prov...
2 CitationsSource
#1Jun Li (Fourth Military Medical University)H-Index: 9
#2Jie Xu (Fourth Military Medical University)H-Index: 13
Last. Feng Gao (Fourth Military Medical University)H-Index: 92
view all 13 authors...
Abstract Background Acute hyperglycemia is regarded as a risk factor for critically ill patients; however, insufficient understanding of its nature and underlying mechanisms hinders widespread adoption of glycemic control in critical care units. Methods A single center, prospective cohort study recruiting 107 burn patients and 62 controls was conducted to characterize the early phase of acute hyperglycemia in burn patients. A total of 1643 blood samples were collected and analyzed over the entir...
2 CitationsSource
#1Ruben Rodriguez (UCM: University of California, Merced)H-Index: 7
#2Andrew Lee (UCM: University of California, Merced)H-Index: 3
Last. Rudy M. Ortiz (UCM: University of California, Merced)H-Index: 19
view all 10 authors...
Pathological activation of the renin-angiotensin system and inflammation are associated with hypertension and the development of metabolic syndrome (MetS). The contributions of angiotensin receptor...
Source
#1Thierry M. Nordmann (University of Basel)H-Index: 3
#2Erez Dror (University of Basel)H-Index: 7
Last. Marc Y. Donath (University of Basel)H-Index: 60
view all 8 authors...
Chronic inflammation impairs insulin secretion and sensitivity. β-cell dedifferentiation has recently been proposed as a mechanism underlying β-cell failure in T2D. Yet the effect of inflammation on β-cell identity in T2D has not been studied. Therefore, we investigated whether pro-inflammatory cytokines induce β-cell dedifferentiation and whether anti-inflammatory treatments improve insulin secretion via β-cell redifferentiation. We observed that IL-1β, IL-6 and TNFα promote β-cell dedifferenti...
23 CitationsSource
#1Harshita Chodavarapu (LSU Health Sciences Center New Orleans)H-Index: 3
#2Kavaljit H. Chhabra (UM: University of Michigan)H-Index: 8
Last. Eric Lazartigues (LSU Health Sciences Center New Orleans)H-Index: 28
view all 6 authors...
While restoration of ACE2 activity in the pancreas leads to improvement of glycemia in experimental models of Type 2 diabetes, global deficiency in ACE2 disrupts β-cell function and impairs glucose tolerance in mice, demonstrating the physiological role of ACE2 in glucose homeostasis. Although the contribution of pancreatic ACE2 to glucose regulation has been demonstrated in genetic models of diabetes and in models with overexpression of the renin-angiotensin system (RAS), it is unclear whether ...
4 CitationsSource
#1Rena PollackH-Index: 3
#2Marc Y. DonathH-Index: 60
Last. Gil LeibowitzH-Index: 30
view all 4 authors...
The association between hyperglycemia and inflammation and vascular complications in diabetes is now well established. Antidiabetes drugs may alleviate inflammation by reducing hyperglycemia; however, the anti-inflammatory effects of these medications are inconsistent and it is unknown whether their beneficial metabolic effects are mediated via modulation of chronic inflammation. Recent data suggest that immunomodulatory treatments may have beneficial effects on glycemia, β-cell function, and in...
41 CitationsSource
Hypertension is recognized as an important risk factor for cardiovascular morbidity and mortality. Lowering of blood pressure has been shown to minimize the risk of cardiovascular events, with the majority of antihypertensives demonstrating a similar ability to reduce coronary events and stroke for a given reduction in blood pressure. Agents that modify the activity of the renin–angiotensin system (RAS) have been proposed to exhibit additional effects that might go beyond simple blood pressure l...
5 CitationsSource
Here, Denise Lackey and Jerrold Olefsky discuss the innate immune cells involved in secreting inflammatory factors during obesity. The role of innate immune cells in maintaining an anti-inflammatory and insulin-sensitive environment in the lean state is also reviewed. This Review also provides an overview of the mechanisms for regulating proinflammatory immune responses that could lead to future therapeutic opportunities to improve insulin sensitivity.
195 CitationsSource
#1C. B. Collares-Buzato (State University of Campinas)H-Index: 18
Type 2 diabetes (T2D) is a multifactorial metabolic disease characterized by a chronic state of hyperglycemia caused by defects in the production as well as in the peripheral action of insulin. Among all the risk factors known to lead to T2D, obesity seems to be the most important one, being invariably associated with intake of overly high-caloric diets rich in lipids. In this chapter, we address a topic that has recently received attention that is the role of exposure to high-fat diets, and par...
2 CitationsSource
Author(s): Lee, Andrew Ying-Ping | Advisor(s): Ortiz, Rudy M | Abstract: Pathological activation of the renin-angiotensin system (RAS) and inflammation are associated with hypertension and the development of metabolic syndrome (MetS). The progression of MetS is also associated with the development of chronic kidney disease (CKD) and nonalcoholic fatty liver disease (NAFLD). However, the contributions of the angiotensin type 1 receptor (AT1) receptor activation and tumor necrosis factor (TNF)-α-m...